5.01BMarket Cap4.78P/E (TTM)
19.890High18.110Low4.58MVolume19.440Open18.830Pre Close87.15MTurnover1.79%Turnover Ratio4.89P/E (Static)257.17MShares22.85152wk High-71.69P/B5.00BFloat Cap10.67152wk Low1.12Dividend TTM256.40MShs Float35.537Historical High5.74%Div YieldTTM9.45%Amplitude10.671Historical Low19.026Avg Price1Lot Size
Organon & Co Stock Forum
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.45%
At the close in NYSE, the Dow Jones Industrial Average fell 0.45%, while the S&P 500 index lost 0.42%, and the NASDAQ Composite index lost 0.79%.
The best performers of the session on the Dow Jones Industrial Average were Amgen Inc ( $Amgen(AMGN.US)$ ), which rose 3.11% or 7.86 points t...
ColumnsUS Top Gap Ups and Downs on 8/8: LLY, FOX, TWKS, DDOG and More
Gap Ups
1. $Novo-Nordisk A/S(NVO.US)$ - up 13.4%
2. $Eli Lilly and Co(LLY.US)$ - up 10.5%
3. $James Hardie Industries(JHX.US)$ - up 10.1%
4. $New York Times(NYT.US)$ - up 3.3%
5. $POSCO(PKX.US)$ - up 2.9%
6. $Fox Corp-B(FOX.US)$ - up 2.8%
7. $Fox Corp-A(FOXA.US)$ - up 2.8%
8. $West Pharmaceutical Services(WST.US)$ - up 2.5...
I should have waited to buy
even right now
ColumnsUS Top Rating Updates on 10/14: MU, DAL, APP, NOC and More
Loop Capital analyst Charles Park initiated coverage of $Micron Technology(MU.US)$ with a Buy rating and $70 price target. The analyst expects DRAM fundamentals to bottom in the first half of 2023 and notes that the shares "typically bottoming a couple of quarters ahead."
AppLovin Initiated With an Outperform at Wedbush
Wedbush analyst Nick McKay initiated coverage of $Applovin(APP.US)$ with an O...
Darė Ovaprene to Start Trial
Darė already has FDA approval for Xaciato with which they announced a partnership with $Organon & Co(OGN.US)$ and expect revenues to begin generating in Q4 2022.
This is a promising bio for the patient investor IMO...
No comment yet